Strategies and Techniques of Reoperation in Differentiated Thyroid Carcinoma_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 朱精强 , 邹秀和 , 马宇

Corresponding author：

朱精强, Email: zjq-wkys@163.com

Keywords：

分化型甲状腺癌; 再次手术; 颈淋巴结清扫; 技巧

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 朱精强,邹秀和,马宇. Strategies and Techniques of Reoperation in Differentiated Thyroid Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2013, 20(9): 957-961. doi: Copy

1.	Mazzaferri EL， Kloos RT. Clinical review 128：current approa-ches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab， 2001， 86(4)：1447-1463.
2.	Lee JW， Yoon DY， Choi CS， et al. Anaplastic thyroid carcinoma：computed tomographic differentiation from other thyroid masses[J]. Acta Radiol， 2008， 49(3)：321-327.
3.	Roh JL， Kim JM， Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer：patterns of recurrence， morbidity， and prediction of postoperative hypocalcemia[J]. Ann Surg Oncol， 2011， 18(5)：1312-1318.
4.	Cooper DS， Doherty GM， Haugen BR， et al. American thyroid association (ATA) guidelines taskforce on thyroid nodules and diff-erentiated thyroid cancer. Revised American thyroid association mana-gement guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid， 2009， 19(11)：1167-1214.
5.	中华医学会内分泌学分会，中华医学会外科学分会内分泌学组，中国抗癌协会头颈肿瘤专业委员会，等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华内分泌代谢杂志， 2012， 28(10)：779-797.
6.	张桂芝，谭建，刘雪辉，等. 131I治疗分化型甲状腺癌术后患者疗效影响因素研究[J]. 中华核医学杂志， 2010， 30(4)：259-263.
7.	Vergez S， Sarini J， Percodani J， et al. Lymph node managementin clinically node-negative patients with papillary thyroid carcinoma[J]. Eur J Surg Oncol， 2010， 36(8)：777-782.
8.	葛智成，屈翔，滕长胜，等. USG和增强CT对甲状腺癌与中央区淋巴结转移的研究[J]. 国际外科学杂志， 2012， 39(2)：87-90.
9.	Xiao GZ， Gao L. Central lymph node metastasis：is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma?[J]. World J Surg， 2010， 34(2)：237-241.
10.	Roh JL， Kim JM， Park CI. Lateral cervical lymph node metastasesfrom papillary thyroid carcinoma：pattern of nodal metastases and optimal strategy for neck dissection[J]. Ann Surg Oncol， 2008， 15(4)：1177-1182.
11.	Lupi C， Giannini R， Ugolini C， et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma[J]. J Clin Endo-crinol Metab， 2007， 92(11)：4085-4090.
12.	Xing M. Prognostic utility of BRAF mutation in papillary thyroid cancer[J]. Mol Cell Endocrinol， 2010， 321(1)：86-93.
13.	Krishnan J， Kirkin V， Steffen A， et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats[J]. Cancer Res， 2003， 63(3)：713-722.
14.	中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版)[J]. 中国实用外科杂志， 2013， 33(6)：470-474.
15.	朱精强. 分化型甲状腺癌颈淋巴结清扫的相关问题[J]. 中国普外基础与临床杂志， 2012， 19(8)：809-813.

1. Mazzaferri EL， Kloos RT. Clinical review 128：current approa-ches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab， 2001， 86(4)：1447-1463.
2. Lee JW， Yoon DY， Choi CS， et al. Anaplastic thyroid carcinoma：computed tomographic differentiation from other thyroid masses[J]. Acta Radiol， 2008， 49(3)：321-327.
3. Roh JL， Kim JM， Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer：patterns of recurrence， morbidity， and prediction of postoperative hypocalcemia[J]. Ann Surg Oncol， 2011， 18(5)：1312-1318.
4. Cooper DS， Doherty GM， Haugen BR， et al. American thyroid association (ATA) guidelines taskforce on thyroid nodules and diff-erentiated thyroid cancer. Revised American thyroid association mana-gement guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid， 2009， 19(11)：1167-1214.
5. 中华医学会内分泌学分会，中华医学会外科学分会内分泌学组，中国抗癌协会头颈肿瘤专业委员会，等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华内分泌代谢杂志， 2012， 28(10)：779-797.
6. 张桂芝，谭建，刘雪辉，等. 131I治疗分化型甲状腺癌术后患者疗效影响因素研究[J]. 中华核医学杂志， 2010， 30(4)：259-263.
7. Vergez S， Sarini J， Percodani J， et al. Lymph node managementin clinically node-negative patients with papillary thyroid carcinoma[J]. Eur J Surg Oncol， 2010， 36(8)：777-782.
8. 葛智成，屈翔，滕长胜，等. USG和增强CT对甲状腺癌与中央区淋巴结转移的研究[J]. 国际外科学杂志， 2012， 39(2)：87-90.
9. Xiao GZ， Gao L. Central lymph node metastasis：is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma?[J]. World J Surg， 2010， 34(2)：237-241.
10. Roh JL， Kim JM， Park CI. Lateral cervical lymph node metastasesfrom papillary thyroid carcinoma：pattern of nodal metastases and optimal strategy for neck dissection[J]. Ann Surg Oncol， 2008， 15(4)：1177-1182.
11. Lupi C， Giannini R， Ugolini C， et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma[J]. J Clin Endo-crinol Metab， 2007， 92(11)：4085-4090.
12. Xing M. Prognostic utility of BRAF mutation in papillary thyroid cancer[J]. Mol Cell Endocrinol， 2010， 321(1)：86-93.
13. Krishnan J， Kirkin V， Steffen A， et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats[J]. Cancer Res， 2003， 63(3)：713-722.
14. 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版)[J]. 中国实用外科杂志， 2013， 33(6)：470-474.
15. 朱精强. 分化型甲状腺癌颈淋巴结清扫的相关问题[J]. 中国普外基础与临床杂志， 2012， 19(8)：809-813.

Next Article
Application of Lymphatic Mapping to Recognize and Protect Negative Stained Parathyroid in Thyroid Carcinoma Surgery by Using Carbon Nanoparticles

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Strategies and Techniques of Reoperation in Differentiated Thyroid Carcinoma

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content